These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 11810594)
1. Efficacy of a 14-day course of oral ciprofloxacin therapy for acute uncomplicated pyelonephritis. Takahashi S; Hirose T; Satoh T; Kato R; Hisasue SI; Takagi S; Shimizu T; Kunishima Y; Matsukawa M; Itoh N; Tsukamoto T J Infect Chemother; 2001 Dec; 7(4):255-7. PubMed ID: 11810594 [TBL] [Abstract][Full Text] [Related]
2. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial. Talan DA; Stamm WE; Hooton TM; Moran GJ; Burke T; Iravani A; Reuning-Scherer J; Church DA JAMA; 2000 Mar 22-29; 283(12):1583-90. PubMed ID: 10735395 [TBL] [Abstract][Full Text] [Related]
3. Rufloxacin once daily versus ciprofloxacin twice daily in the treatment of patients with acute uncomplicated pyelonephritis. Bach D; van den Berg-Segers A; Hübner A; van Breukelen G; Cesana M; Plétan Y J Urol; 1995 Jul; 154(1):19-24. PubMed ID: 7776420 [TBL] [Abstract][Full Text] [Related]
4. Once daily, extended release ciprofloxacin for complicated urinary tract infections and acute uncomplicated pyelonephritis. Talan DA; Klimberg IW; Nicolle LE; Song J; Kowalsky SF; Church DA J Urol; 2004 Feb; 171(2 Pt 1):734-9. PubMed ID: 14713799 [TBL] [Abstract][Full Text] [Related]
5. Comparison of sparfloxacin and ciprofloxacin in the treatment of community-acquired acute uncomplicated urinary tract infection in women. Sparfloxacin Multicenter Uncomplicated Urinary Tract Infection Study Group. Henry DC; Nenad RC; Iravani A; Tice AD; Mansfield DL; Magner DJ; Dorr MB; Talbot GH Clin Ther; 1999 Jun; 21(6):966-81. PubMed ID: 10440621 [TBL] [Abstract][Full Text] [Related]
6. Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial. Sandberg T; Skoog G; Hermansson AB; Kahlmeter G; Kuylenstierna N; Lannergård A; Otto G; Settergren B; Ekman GS Lancet; 2012 Aug; 380(9840):484-90. PubMed ID: 22726802 [TBL] [Abstract][Full Text] [Related]
7. A trial of levofloxacin 750 mg once daily for 5 days versus ciprofloxacin 400 mg and/or 500 mg twice daily for 10 days in the treatment of acute pyelonephritis. Klausner HA; Brown P; Peterson J; Kaul S; Khashab M; Fisher AC; Kahn JB Curr Med Res Opin; 2007 Nov; 23(11):2637-45. PubMed ID: 17880755 [TBL] [Abstract][Full Text] [Related]
8. Prospective, randomized, controlled study comparing two dosing regimens of gentamicin/oral ciprofloxacin switch therapy for acute pyelonephritis. Bailey RR; Begg EJ; Smith AH; Robson RA; Lynn KL; Chambers ST; Barclay ML; Hornibrook J Clin Nephrol; 1996 Sep; 46(3):183-6. PubMed ID: 8879853 [TBL] [Abstract][Full Text] [Related]
9. Oral vs intravenous ciprofloxacin in the initial empirical management of severe pyelonephritis or complicated urinary tract infections: a prospective randomized clinical trial. Mombelli G; Pezzoli R; Pinoja-Lutz G; Monotti R; Marone C; Franciolli M Arch Intern Med; 1999 Jan; 159(1):53-8. PubMed ID: 9892331 [TBL] [Abstract][Full Text] [Related]
10. Comparison of once-daily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women. Henry DC; Bettis RB; Riffer E; Haverstock DC; Kowalsky SF; Manning K; Hamed KA; Church DA Clin Ther; 2002 Dec; 24(12):2088-104. PubMed ID: 12581547 [TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, multicenter comparison of gatifloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection and pyelonephritis. Cox CE; Marbury TC; Pittman WG; Brown GL; Auerbach SM; Fox BC; Yang JY Clin Ther; 2002 Feb; 24(2):223-36. PubMed ID: 11911553 [TBL] [Abstract][Full Text] [Related]
12. A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis. Peterson J; Kaul S; Khashab M; Fisher AC; Kahn JB Urology; 2008 Jan; 71(1):17-22. PubMed ID: 18242357 [TBL] [Abstract][Full Text] [Related]
13. A Seven-Day Course of TMP-SMX May Be as Effective as a Seven-Day Course of Ciprofloxacin for the Treatment of Pyelonephritis. Fox MT; Melia MT; Same RG; Conley AT; Tamma PD Am J Med; 2017 Jul; 130(7):842-845. PubMed ID: 28216442 [TBL] [Abstract][Full Text] [Related]
14. Levofloxacin versus ciprofloxacin versus lomefloxacin in acute pyelonephritis. Richard GA; Klimberg IN; Fowler CL; Callery-D'Amico S; Kim SS Urology; 1998 Jul; 52(1):51-5. PubMed ID: 9671870 [TBL] [Abstract][Full Text] [Related]
15. Empirical use of ciprofloxacin for acute uncomplicated pyelonephritis caused by Escherichia coli in communities where the prevalence of fluoroquinolone resistance is high. Jeon JH; Kim K; Han WD; Song SH; Park KU; Rhee JE; Song KH; Park WB; Kim ES; Park SW; Kim NJ; Oh MD; Kim HB Antimicrob Agents Chemother; 2012 Jun; 56(6):3043-6. PubMed ID: 22391544 [TBL] [Abstract][Full Text] [Related]
16. Ciprofloxacin extended release: in the treatment of urinary tract infections and uncomplicated pyelonephritis. Waugh J; Keating GM Drugs Aging; 2004; 21(1):55-64; discussion 65-6. PubMed ID: 14715044 [TBL] [Abstract][Full Text] [Related]
17. Single-dose fluoroquinolone therapy of acute uncomplicated urinary tract infection in women: results from a randomized, double-blind, multicenter trial comparing single-dose to 3-day fluoroquinolone regimens. Richard GA; Mathew CP; Kirstein JM; Orchard D; Yang JY Urology; 2002 Mar; 59(3):334-9. PubMed ID: 11880065 [TBL] [Abstract][Full Text] [Related]
18. A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group. McCarty JM; Richard G; Huck W; Tucker RM; Tosiello RL; Shan M; Heyd A; Echols RM Am J Med; 1999 Mar; 106(3):292-9. PubMed ID: 10190377 [TBL] [Abstract][Full Text] [Related]
19. Current issues in the management of urinary tract infections: extended-release ciprofloxacin as a novel treatment option. Blondeau JM Drugs; 2004; 64(6):611-28. PubMed ID: 15018591 [TBL] [Abstract][Full Text] [Related]
20. Is a 7-day course of ciprofloxacin effective in the treatment of uncomplicated pyelonephritis in women? Rosenbaum D; Luther S; Krist A J Fam Pract; 2000 Jun; 49(6):573-4. PubMed ID: 10923561 [No Abstract] [Full Text] [Related] [Next] [New Search]